CTHRC1 Derived From Cancer‐Associated Fibroblasts Promotes Pancreatic Cancer Progression and Metastasis via the LIF‐STAT3 Pathway [PDF]
Background Collagen triple helix repeat containing 1 (CTHRC1) is a secreted protein involved in tissue remodeling and fibrotic processes, which also suggests emerging roles in cancer.
Hang Yin +8 more
doaj +3 more sources
Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. [PDF]
Collagen triple helix repeat-containing 1 (CTHRC1), a novel oncogene, was identified to be aberrantly overexpressed in several malignant tumors. However, the expression profile of CTHRC1 and its clinical significance in non-small cell lung cancer (NSCLC) remain unknown.
Ke Z +7 more
europepmc +4 more sources
Identification of CTHRC1 as a novel candidate for neurodevelopmental disorders [PDF]
BackgroundCognitive dysfunction affects over 50 million individuals worldwide, with Alzheimer’s disease (AD) representing two-thirds of cases. We identified CTHRC1 (Collagen Triple Helix Repeat Containing 1) as a novel candidate associated with cognitive
Jie Xu +8 more
doaj +2 more sources
CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma [PDF]
Colon cancer, thyroid cancer, and melanoma are common malignant tumors that seriously threaten human health globally. The B-Raf proto-oncogene, serine/threonine kinase (BRAF)(V600E) mutation is an important driver gene mutation in these cancer types. In
Rumeng Zhang +10 more
doaj +2 more sources
CTHRC1/TGF-β/Smad axis serves as therapeutic targets in inhibiting oral squamous cell carcinoma by mediating ferroptosis [PDF]
Background Collagen triple helix repeat containing 1 (CTHRC1) is an oncogene in numerous human cancers including oral squamous cell carcinoma (OSCC). However, whether and how CTHRC1 influences OSCC progression through ferroptosis has not been completely ...
Shihao Huang +5 more
doaj +2 more sources
Collagen triple helix repeat containing 1 (Cthrc1) has been recently documented in various malignancies, but its role in non-small cell lung cancer (NSCLC) remains uncertain. In the current study, we investigated the level of Cthrc1 in NSCLC tissues by immunohistochemistry.
Xiaojun, Liu +5 more
exaly +3 more sources
CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway
Tendinopathy poses a formidable challenge due to the inherent limitations of tendon regenerative capabilities post‐injury. At present, effective curative approaches for tendinopathy are still lacking. Collagen triple helix repeat‐containing 1 (CTHRC1) is
Cheng Chen +6 more
doaj +2 more sources
Assessment of Plasma Level of CTHRC-I in Patients with Rheumatoid Arthritis
Background: Rheumatoid arthritis (RA) is a chronic progressive, autoimmune disease that affects about 1.5% of the community. New markers are needed for early diagnosis of RA as seronegativity in early RA remains a major limitation of both anti ...
Sahar Alwan, Raja Abdul-Ridha, Alaa Ali
doaj +9 more sources
CTHRC1: a key player in colorectal cancer progression and immune evasion [PDF]
The multifunctional secreted protein, collagen triple helix repeat containing 1 (CTHRC1), has recently emerged as a significant focus within oncology research.
Qingjie Chen +3 more
doaj +2 more sources
Expression, Prognostic Value, and Biological Function of CTHRC1 in Different Types of Gliomas: A Bioinformatic Analysis and Experiment Validation [PDF]
Background: In recent years, abnormal expression of collagen triple helix repeat containing 1 (CTHRC1) has been found in some tumors, closely related to the poor prognosis of cancer patients. However, the clinical significance of CTHRC1 in gliomas is not
Xueping Shi +7 more
doaj +2 more sources

